US 9828432
Cancer treatment and monitoring methods using OX40 agonists
granted A61KA61K2039/505A61K2039/6031
Quick answer
US patent 9828432 (Cancer treatment and monitoring methods using OX40 agonists) held by Providence Health & Services—Oregon expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Providence Health & Services—Oregon
- Grant date
- Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/6031, A61P, A61P35/00